Axios Alerts: Trump and Biden near end of Super Tuesday in dominant fashion

Alerts   Axios    Trump and Biden near end of Super Tuesday in dominant fashion Why it matters: On the biggest voting day before November, the frontrunners easily won most states, including Texas and California.   Axios thanks our partners for supporting our newsletters. Sponsorship has no influence on editorial content. Axios, 3100 Clarendon B‌lvd, Arlington VA 22201   You received this email because you signed up for newsletters from Axios. To stop receiving this newsletter, unsubscribe or manage your email preferences.   Was this email forwarded to you? Sign up now to get Axios in your inbox.   Follow Axios on social media:

                                             

50-Year Wall Street Veteran Issues NVDA warning…

Time to Sell NVDA? Wall Street Veteran Weighs In.....................................................................................................................................................................................................................................

Unsubscribe Time to Sell NVDA? 50-Yr Wall Street Legend Weighs In After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months.  (In fact, it's officially the most-traded stock on Wall Street today. Even AI superfan Cathie Woods is offloading her shares.)  So if you currently own NVIDIA (NVDA)...  Or were thinking of buying it in the weeks ahead...  I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin, before you move your money in or out of the stock.  You can watch it here. You see, Marc's award-winning stock-rating system flashed "BUY" on NVIDIA back in February 2023 - before it quickly doubled in less than six months. Now, he says there's a BETTER AI stock to buy than NVDA right now, especially for those interested in finding the biggest potential gains in the coming $7 trillion A.I. boom.  He just named its name and ticker - 100% free.  You can get all the details by clicking the link below. I'll see you there. Regards, Kelly Brown Senior Researcher, Chaikin Analytics This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here. This is a PAID ADVERTISEMENT provided to the subscribers of StockEarnings Free Newsletter. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe . StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com

LIVE Online Workshop: “Scalping” Secrets Revealed

LIVE online Scalping workshop March 6 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Dear Trader, True story: At 9:30 a.m. on January 8 this year, I was online with some of my traders when a particular chart pattern appeared. We were watching the 15-minute chart of the SPDR S&P 500 ETF Trust, known as SPY. Whenever I see this one particular pattern, I jump.  I instantly bought four SPY call options for the price of $3.42 ($342 per contract), or $1,710 total. Exactly four minutes later, a second chart pattern I was expecting appeared, telling me to SELL. Which I did. I made $115 in four minutes – for a total gain of 6.73%. Now, that might not sound like much.  But a few minutes later, at 10:42, I did the same thing again.  The same pattern reappeared.  This time I bought TEN contracts for the price of only $47 each or $470 total invested. Seven minutes later, I sold for a $90 profit (19.15% gain). Then I did it once again:  I bought and sold 10 options for a total profit of $200 (or 40% gain).  In 9 minutes. Total profit overall: $405. By the way, these were real trades made with real money, not some simulated or hypothetical trades. Here are the details: Again, $405 may not seem like a lot.  But if someone did the same every trading day, and there are approximately 250 trading days in a year, that’s potentially an extra $102,000 a year. My name is Hugh Grossman, founder and chief instructor of DayTradeSPY.com. Today I’d like to invite any and all traders to a LIVE online training workshop where I demonstrate precisely how I do these trades in real time. We call this type of trading “scalping.” That’s because we “scalp” a few pennies off the price of an option during an up or down trend. The truth is, it’s not rocket science. But we do have a secret: a very specific method for identifying winning trades as they appear. In fact, once someone learns a few tricks of the trade, making money this way may become boring. But after dozens and dozens of comments asking me to reveal my go-to trading strategy, I thought it was time to pull back the curtain and host our “Scalping Strategy” workshop. It starts promptly 11:30 AM ET on Wednesday, March 6, 2024. During this hour-long LIVE online workshop, my partner Ahren Stephens and I pull back the curtain on trading and show what works in the real world. We reveal the simple but powerful secrets that help even less experienced option traders make hundreds of dollars in a matter of minutes.  During the upcoming workshop, you’ll discover... How to make easy profits by trading in and out for quick gains… The 5 simple setups that enable consistent profits from rapid trades… How tight stop losses control risk while stacking up many quick gains… The secrets of using multiple time frames to confirm entry points… The simple tweak that let one new trader go from regular losses to consistent profits… How to take advantage of market volatility to bank bigger profits with Scalp Trades… Simple steps for optimizing a trading setup to maximize efficiency… The rules to identify ideal entry and target prices in seconds simply by reading stock charts… How riding market waves for small, repeated gains can earn a fortune… And lots MORE! In short: This is a jam-packed LIVE online workshop that anyone who trades or is interested in trading shouldn’t miss. Everything we go over is based on real-world trading that we do almost every day with students in LIVE trading. And here’s the best part:  for what Ahren and I share during one of these workshops, I could easily charge $249 for this.  For those who act right away and reserve a space now, the price is only $199. However, please don’t dilly-dally.  We are limiting the number of people who can attend at this price. Reserve a place now and pay only $199.  Click on the button below.  Once your spot is reserved, we’ll send the details about how to log on for the workshop... how to access the recorded version after the live event (included in the price)... and more information about DayTradeSPY and trading. So, click on the big button now, and let’s learn how to make money trading! Reserve Your Spot! Best wishes, Hugh Grossman DayTradeSPY To ensure future delivery of Eagle Financial Publication's emails please add the domain @info2.eaglefinancialpublications.com to your address book or contact list. This email was sent to edwardlorilla1986.paxforex@blogger.com because you are subscribed to the Information about Financial Newsletters from Eagle Financial Publications List. To unsubscribe please click here. To instantly stop receiving emails simply click here. View this email in your web browser. If you have questions, please send them to Customer Service. © Eagle Financial Publications - Eagle Products, LLC. - a Salem Communications Holding Company. All rights reserved. 122 C Street NW, Suite 515 | Washington, D.C. 20001

Link

What’s not in Congress’ health funding deal

Presented by Kidney Care Access: The ideas and innovators shaping health care

Mar 05, 2024 View in browser   By Daniel Payne, Ruth Reader and Erin Schumaker Presented by WASHINGTON WATCH Charlie Neibergall/AP Photo "This funding deal is not the end of the discussion. It is just the beginning." Sen. Bernie Sanders, I-Vt. A bipartisan deal to fund the FDA and the VA would mitigate cuts to doctors’ Medicare reimbursements and boost funding for community health centers. But it’s the policies that didn’t make the funding package unveiled over the weekend that have the chair of the Senate’s health panel, Bernie Sanders (I-Vt.), perturbed. How’s that? Sanders decried Congress’ inability to pass a larger package — something his committee has worked on for months, gaining bipartisan backing — that would create more stability and predictability in the government’s funding streams. Sanders’ panel in September approved legislation he drafted with Sen. Roger Marshall (R-Kan.) that would provide billions in funding for community health centers and bolster the doctor, nursing and dentist workforces. But little of that made it into the deal that Congress will likely pass this month. Community health center advocates echoed Sanders’ sentiment, applauding the funding increases while asking leaders to find long-term solutions. And doctors' groups, frustrated that the package eliminated only part of a 3.4 percent pay cut that took effect in January, have for months lobbied Congress to change the reimbursement formula that has caused HHS to seek annual cuts to doctors’ reimbursements. Even so: Leaders in Congress and some provider groups are happy to see even temporary updates to their payments, ending months of limbo. Lawmakers and lobbyists have already begun working to craft — and influence — long-term legislation with an eye toward passing it before the end of the year.   A message from Kidney Care Access: Dialysis patients and their families are being harmed. Employer group health plans can discriminate against patients with kidney failure, disrupting coverage for the patient and their family. A new bipartisan bill will restore essential protections as Congress intended – for these patients and their families. Congress: pass H.R. 6860, the bipartisan Restore Protections for Dialysis Patients Act. Protect patients and their families. Learn more.   WELCOME TO FUTURE PULSE Washington, D.C. | Shawn Zeller/POLITICO This is where we explore the ideas and innovators shaping health care. A key detail is getting lost in the congressional drama over our nation's beleaguered organ donation system, a transplant surgeon writes in a STAT News op-ed: Transplant centers and surgeons are turning kidneys down. Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com or Erin Schumaker at eschumaker@politico.com. Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.    A message from Kidney Care Access:   TECH MAZE Johns Hopkins is among the health systems collaborating on new AI standards. | Getty Images Government has allowed health systems to adopt advanced AI tools without much oversight — and even the systems think that's risky. So leading health care organizations, including Johns Hopkins University, the Mayo Clinic and Stanford Medicine, are pushing new guidelines to ensure that artificial intelligence is safe and effective. They helped develop the guidelines as part of the Coalition for Health AI, or CHAI. And the coalition, which also includes tech giants Google and Microsoft, plans to set up private-sector “assurance labs” to start vetting AI tools before summer’s over. “One of the ultimate goals and hopes is building transparency to help build trust and identify spots where AI is not working well,” Dr. Brian Anderson, a co-founder of CHAI and chief digital health physician at MITRE, a nonprofit that advises government agencies on tech issues, told POLITICO’s Ben Leonard. Why it matters: The move by CHAI — the effort includes help from the White House and various federal health agencies — comes as regulators and lawmakers weigh how to regulate the emerging technology. HHS has previously backed the idea of AI assurance labs, and FDA Commissioner Robert Califf has floated them as one alternative to establishing a vast new bureaucracy of civil servants charged with monitoring AI tools. What’s next? Anderson said CHAI hopes to publish report cards about the tools. Dr. John Halamka, who will chair the coalition’s board and is president of the Mayo Clinic Platform, is eyeing a nationwide network of labs — not just one. “The only way to do this is in a very federated and distributed way,” Halamka said, suggesting major universities could host them.   A message from Kidney Care Access: A recent Supreme Court ruling now allows employer group health plans to discriminate against patients with kidney failure and disrupt coverage for the entire family – spouse and kids. The Bipartisan Restore Protections for Dialysis Patients Act reverses the negative, unintended consequences of the Supreme Court’s ruling by simply restoring long-standing protections put in place by Congress for patients and their families. Congress: restore what’s right. Pass H.R. 6860, the Bipartisan Restore Protections for Dialysis Patients Act. Learn more.     CONGRESS OVERDRIVE: Since day one, POLITICO has been laser-focused on Capitol Hill, serving up the juiciest Congress coverage. Now, we’re upping our game to ensure you’re up to speed and in the know on every tasty morsel and newsy nugget from inside the Capitol Dome, around the clock. Wake up, read Playbook AM, get up to speed at midday with our Playbook PM halftime report, and fuel your nightly conversations with Inside Congress in the evening. Plus, never miss a beat with buzzy, real-time updates throughout the day via our Inside Congress Live feature. Learn more and subscribe here.     FOLLOW THE MONEY FTC Chair Lina Khan is examining private equity's growing role in health care. | Saul Loeb/AP More than 5,000 physicians are joining forces to oppose private equity’s expanding footprint in health care. OrthoForum, the Association for Independent Medicine, and the Physician Empowered Leadership of Transformational Organizations are among the founders of the new Coalition for Patient-Centered Care that’s hoping to influence policy at both the state and federal level. The coalition’s policy goals include:  — Eliminating tax breaks when private equity acquires physician groups — Subjecting private equity to the same requirements and regulations as physician acquisitions — Increasing reporting and transparency requirements for private equity groups that acquire physician practices Why it matters: Private equity firms are buying up physician practices. A report released last year found that private equity acquisitions of doctor practices increased six-fold over the course of a decade, from 75 to 484 deals between 2012 and 2022. The report found private equity-backed groups are associated with higher health care prices, particularly if a group controlled more than 30 percent of the regional market. In addition to higher costs, private equity backing worsens patient care, the coalition argues. The coalition already has allies in Congress, including Rep. Lori Trahan (D-Mass.), who criticized the private equity-backed hospital model during a congressional hearing in January, pointing to hospitals in her district that were purchased by private equity and then slated to close. In the Senate, Chuck Grassley (R-Iowa) and Sheldon Whitehouse (D-R.I.) launched an investigation last year into private equity ownership of hospitals. Private equity firms dispute the coalition’s assessment of their impact on health care. They cite research that found private equity-backed hospitals have better staff-to-patient ratios and pay than health systems that don’t have private equity owners. What's next? Some coalition members are trying to recruit patient, consumer, and employer groups. Others want to gather more momentum among doctors and eventually get some of the bigger physician groups to participate. The Federal Trade Commission also has eyes on private equity. The FTC is hosting a workshop today examining private equity's impact on health care. Karen Simonton, CEO of the OrthoForum will speak at today's FTC event. In a letter to FTC Chair Lina Khan, the general counsel of the industry-backed American Investment Council, Rebekah Goshorn Jurata, said that “private equity investments consistently support quality, affordable health care for patients.”   DON’T MISS POLITICO’S HEALTH CARE SUMMIT: The stakes are high as America's health care community strives to meet the evolving needs of patients and practitioners, adopt new technologies and navigate skeptical public attitudes toward science. Join POLITICO’s annual Health Care Summit on March 13 where we will discuss the future of medicine, including the latest in health tech, new drugs and brain treatments, diagnostics, health equity, workforce strains and more. REGISTER HERE.       Follow us on Twitter Carmen Paun @carmenpaun Daniel Payne @_daniel_payne Ruth Reader @RuthReader Erin Schumaker @erinlschumaker   Follow us

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA Unsubscribe | Privacy Policy | Terms of Service

Urgent 2024 AI Prediction By Legend Who Picked Samsara, Gitlab & Crowdstrike

Don't let it happen again. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe A Message from The Oxford Club Dear Reader,   Don’t let it happen again.   In 2023, we saw certain A.I investments like: C3.ai and Upstart Holdings soar by 159% and 217%, respectively…   We saw the path to A.I. riches with some incredible overnight gains for companies that use AI. Gains like, 345%... 511%... and 3,100%!   And while those stories are in the rear view mirror…   Legendary tech investor, Alex Green, is bringing an important announcement for any Main Street investor looking to profit big from AI in 2024.   He claims:   Starting today, YOU have a SECOND CHANCE to for A.I. riches   Because a brand new “Phase 2” in AI development will open the window for an even larger, faster, investment opportunity…   One that is set to deliver gains many times BIGGER than the incredible results we have already seen in AI.   How many times bigger?   Barron’s says this AI development can grow the U.S. economy by a whopping 10,000%.   Investment bank, UBS Group published: “We upgrade our AI revenue forecasts to 15x growth between 2022 and 2027.”   Top investor Paul Tudor Jones predicts we will see: “Stocks shoot higher for the next 5 to 10 years… With huge individual winners up [for the taking.]”   And if you make just one move with your money today…   One move which Alex Green himself will detail for FREE in this special presentation…   You can potentially grab one of these winners to begin amassing your tidy fortune.   Click here now for his FREE urgent briefing.   Good investing,    Alexander Green Chief Investment Strategist, The Oxford Club

This message is a paid advertisement sent on behalf of The Oxford Club, a third-party advertiser of MarketBeat. Why did I receive this email?     This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, please click here     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Will Crypto Make People Rich Again Starting April, 2024?